2nd International Conference On Tocotrienols And Chronic Diseases at Wynn Resort, Las Vegas, July2011

Printer-friendly versionPDF version

Latest research studies, technical application as well as market potential of palm tocotrienol complex will be shared in this conference

New Jersey, USA – The largest and only GMP-certified tocotrienol producer, Carotech Inc, is pleased to announce that the Malaysian Palm Oil Board (MPOB) will hold its 2nd International Conference on “Tocotrienols and Chronic Diseases” from July 13 – 14 at Wynn Resort, Las Vegas, Nevada, USA.

Significant body of science and increasing number of research studies using Tocomin SupraBio® – patented and bioenhanced full spectrum palm tocotrienol complex have revealed promising results in supporting healthy brain in stroke-related injuries, cholesterol lowering, radiation protection, treatment for non-alcoholic fatty liver disease, anti-inflammation, chemoprevention and, cancer cells apoptosis, acceleration of wound healing and scar reduction post surgery. These are some of the scientific sessions that will be presented during the conference. Other sessions include technical application aspects of tocotrienol and tocotrienol’s market potential.

This two-day conference will feature impressive line-up of speakers invited from all over the world. These are renowned professors and researchers who have spent many years studying palm tocotrienol/tocopherol complex – the only source of tocotrienol with the most science and scientific publication.

The recent FDA’s final notification of no objection for GRAS status of palm tocotrienol complex (Tocomin®, Carotech Inc.) allows it to be used in food and beverage products.

“Carotech is excited to be part of this MPOB Tocotrienol and Chronic Diseases Conference,” says Mr. WH Leong, Vice President, Carotech Inc. “This year, the Conference is going into its second year at Wynn Resort, Las Vegas; and we see an even wider scope of unique health related benefits of palm tocotrienol complex that will be shared with the attendees.”

“Carotech’s Tocomin® and Tocomin SupraBio® are used in most of the tocotrienol studies. Being the largest and the only GMP-certified tocotrienol producer in the world, Carotech will continue to emphasize on solid science and clinical trials to promotes is Tocomin® / Tocomin SupraBio® natural full spectrum palm tocotrienol complex ,” added Mr. Leong.

Registration for this conference is free. Please contact Mr. Bryan See at +1 (732) 906 1901 or email klsee@carotech.net or cmlai@carotech.net for further details.

About Carotech

Carotech, incorporated in 1990, is a public listed company in Malaysia (ACE Market). It was the first producer in the world of natural full spectrum tocotrienol/tocopherol complex (Tocomin® & TocominSupraBio®), natural mixed carotene complex (Caromin®) and phytosterol complex (Stelessterol™) via its patented technology.

Besides being the largest producer of tocotrienol, Carotech is also the only GMP-Certified tocotrienol producer in the world.

Tocomin SupraBio® is a patented (US Patent No. 6,596,306) self emulsifying palm tocotrienol complex that ensures optimal tocotrienols oral absorption.

Carotech is a subsidiary of Hovid Ltd (www.hovid.com), one of the largest GMP-certified pharmaceutical companies in Malaysia.

Carotech manufactures these products under the tradenames: Tocomin®, Tocomin SupraBio®, Caromin® and Stelessterol™.

Websites: www.carotech.net and www.tocotrienol.org

Contact:
Mr. Bryan See, Carotech Inc, USA
Tel : +1 732 906 1901
Email : klsee@carotech.net

Mr. WH Leong, Vice President, Carotech, Australia
E-mail: carot3@aol.com

Dr. Sharon Ling, Carotech, UK
Email : sling@carotech.net